Electrical and medication combination therapy for sleep apnea
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests whether combining electrical stimulation (via an Inspire device you already have or will get) with two medications can better treat obstructive sleep apnea. You'll help researchers understand if this combination works better than the device alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–79 years old and have been diagnosed with obstructive sleep apnea (OSA)
- You have an Inspire device implanted or are scheduled to have one implanted
- You are willing to temporarily turn off your Inspire device for up to 6 weeks during the study
- You do not have uncontrolled medical conditions like heart disease, kidney disease, or liver disease
- You are not currently taking SSRIs, SNRIs, or anticholinergic medications, and cannot take them during the study
- You do not have a history of recent traffic accidents caused by sleepiness, and you do not drive professionally
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This study tests if removing the tonsils together with implanting a nerve stimulator (Hypoglossal Nerve Stimulation) can better treat sleep apnea in people whose throat sides collapse during sleep.
This study tests whether atomoxetine and DAW2022 can improve how severe obstructive sleep apnea is. It may help by changing breathing patterns during sleep, measured through physiology tests.
This trial tests a nerve-stimulation implant for sleep apnea when other treatments haven't worked. It may help if you have moderate to severe apnea, a BMI under 32, and have tried CPAP and a mouth device without success.
This trial tests a new nerve-stimulation therapy called Neuromod to treat moderate-to-severe sleep apnea in people who do not have access to other treatments. If you qualify, you would be part of a study to see if this implant helps improve your breathing during sleep.
This trial tests a nerve stimulation treatment for obstructive sleep apnea in people who are overweight and cannot tolerate CPAP. It focuses on how the treatment affects metabolism and weight.
Hear when a new Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.